Unclaimed brand
NeuroSpeechAI revolutionizes therapy for brain injury, stroke, and dementia patients through a suite of seven innovative apps. Incorporated in April 2023 as a UCL spinout by Professors Jenny Crinion and Alex Leff we merge advanced mobile game development with a groundbreaking, tailored speech recognition system. Our apps are designed to understand and support distorted vision and speech, enabling patients to use them independently for home-based therapy, while providing immediate, robust feedback on their progress. Our technology not only offers personalized therapeutic exercises but also employs algorithmic AI to continuously enhance the platform based on user performance data. This approach ensures that each patient's experience is engaging, effective, and directly contributes to the improvement of their recovery. Available for both mobile and desktop, NeuroSpeechAI's mission is to make quality therapy accessible to everyone affected by acquired visual and language disorders. By offering our therapies on a global scale, we aim to speed up recovery and significantly improve the quality of life for our users, all from the comfort of their home. Dedicated to breaking down barriers in therapy access, NeuroSpeechAI is a testament to the power of combining medical research with digital innovation to create real-world solutions for those in need.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#41D1FF
Dodger Blue
65, 209, 255
195, 100, 63
75, 18, 0, 0
#000A1E
Blue Charcoal
0, 10, 30
220, 100, 6
100, 67, 0, 88
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
Neurospeech AI develops digital neurorehabilitation apps designed to support language and visual recovery after brain injury, stroke, and in some cases dementia. Developed at University College London, its training programs use artificial intelligence to adapt exercises to each person’s speech, language, or visual abilities. The company combines personalized practice with game-based activities intended to engage users, encourage consistent training, and track progress.
Available apps address specific challenges, including reading speed, word reading, visual search, and spoken-language comprehension. Other programs for speech production, naming, and visual-spatial awareness are described as coming soon or undergoing clinical trials. Neurospeech AI presents its rehabilitation approach as grounded in scientific research and clinical evidence, citing peer-reviewed studies on digital therapies for aphasia, reading difficulties, and visual impairments such as hemianopia.
The founding team brings expertise in cognitive rehabilitation, brain and language recovery, and digital therapy research. Neurospeech AI’s products are intended to make structured rehabilitation training accessible through digital tools, with exercises tailored to individual abilities and recovery goals.
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
The NeuroSpeechAI name, logos and brand assets are trademarks of NeuroSpeechAI and its affiliates. Brandfetch isn't affiliated with or endorsed by NeuroSpeechAI. Their use is subject to NeuroSpeechAI's brand guidelines.
